AU8028600A - Methods, pharmaceutical and therapeutic compositions for administering adenosine - Google Patents

Methods, pharmaceutical and therapeutic compositions for administering adenosine

Info

Publication number
AU8028600A
AU8028600A AU80286/00A AU8028600A AU8028600A AU 8028600 A AU8028600 A AU 8028600A AU 80286/00 A AU80286/00 A AU 80286/00A AU 8028600 A AU8028600 A AU 8028600A AU 8028600 A AU8028600 A AU 8028600A
Authority
AU
Australia
Prior art keywords
pharmaceutical
methods
therapeutic compositions
administering adenosine
adenosine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU80286/00A
Inventor
Eliezer Rapaport
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU8028600A publication Critical patent/AU8028600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
AU80286/00A 1999-10-20 2000-10-18 Methods, pharmaceutical and therapeutic compositions for administering adenosine Abandoned AU8028600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16063499P 1999-10-20 1999-10-20
US60160634 1999-10-20
PCT/US2000/028769 WO2001028528A1 (en) 1999-10-20 2000-10-18 Methods, pharmaceutical and therapeutic compositions for administering adenosine

Publications (1)

Publication Number Publication Date
AU8028600A true AU8028600A (en) 2001-04-30

Family

ID=22577721

Family Applications (1)

Application Number Title Priority Date Filing Date
AU80286/00A Abandoned AU8028600A (en) 1999-10-20 2000-10-18 Methods, pharmaceutical and therapeutic compositions for administering adenosine

Country Status (3)

Country Link
EP (1) EP1221945A4 (en)
AU (1) AU8028600A (en)
WO (1) WO2001028528A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001068104A1 (en) 2000-03-16 2001-09-20 The Mclean Hospital Corporation Compounds for the treatment of psychiatric or substance abuse disorders
US7629329B2 (en) * 2001-06-04 2009-12-08 Tsi Health Sciences, Inc. Method for increasing muscle mass and strength through administration of adenosine triphosphate
US20030069203A1 (en) * 2001-06-04 2003-04-10 Lee Steve S. Method for increasing human performance by reducing muscle fatigue and recovery time through oral administration of adenosine triphosphate
EP1784199A4 (en) * 2004-08-11 2010-06-23 Mclean Hospital Corp Compounds for the treatment of marihuana dependence, withdrawal, and usage

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049372A (en) * 1982-07-13 1991-09-17 Eliezer Rapaport Anticancer activities in a host by increasing blood and plasma adenosine 5'-triphosphate (ATP) levels
JPH01308232A (en) * 1988-06-03 1989-12-12 Takeda Chem Ind Ltd Solid drug and production thereof
JPH01308231A (en) * 1988-06-03 1989-12-12 Takeda Chem Ind Ltd Stabilized pharmaceutical composition and production thereof
US5300298A (en) * 1992-05-06 1994-04-05 The Pennsylvania Research Corporation Methods of treating obesity with purine related compounds
US5547942A (en) * 1994-01-04 1996-08-20 Rapaport; Eliezer Method of treatment of diabetes mellitus by administration of adenosine 5'-t
US5900407A (en) * 1997-02-06 1999-05-04 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with uridine triphosphates and related compounds

Also Published As

Publication number Publication date
EP1221945A1 (en) 2002-07-17
EP1221945A4 (en) 2005-06-15
WO2001028528A1 (en) 2001-04-26

Similar Documents

Publication Publication Date Title
AU4300701A (en) Methods and compositions for administration of therapeutic reagents
AU3957600A (en) Piperidyl-imidazole derivatives, their preparations and therapeutic uses
AU6271401A (en) Drug administering system and administering method
HUP0103341A3 (en) Azetidine derivatives, preparation and pharmaceutical compositions thereof
HUP0204515A3 (en) 4-aminopiperidine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
AU5326100A (en) Pharmaceutical compositions and methods for use
AU2922600A (en) Pyridopyranoazepine derivatives, preparation and therapeutic use
AU9018898A (en) Phosphazole-containing nucleoside analogs, related compounds, pharmaceutical compositions thereof, and their use in in vitro medicinal treatments
AU1887401A (en) Medicinal composition
AUPP968699A0 (en) Therapeutic compositions and method for their preparation
ZA200308221B (en) Pharmaceutical compositions for oral and topical administration.
AU4328800A (en) Pharmaceutical formulation
HRPK20010706B1 (en) Tolperison-containing, pharmaceutical preparation for oral administration
HUP0201649A2 (en) Purine derivatives, preparation method and pharmaceutical compositions containing same
AU6715600A (en) Pharmaceutical formulations
AU2002359618A1 (en) Medicinal compositions and therapeutic methods
AU3913900A (en) Radioenhanced cancer treatment using orally administered camptothecin derivatives
AU3971500A (en) Indazole derivatives, preparation and therapeutic application thereof
AU4977300A (en) Pharmaceutical formulations
HUP0500958A2 (en) 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them, therapeutic use thereof and pharmaceutical compositions containing them
AU1385801A (en) Pharmaceutical formulations
AU8028600A (en) Methods, pharmaceutical and therapeutic compositions for administering adenosine
AU3926000A (en) Methods and compositions for drug delivery
AU5587800A (en) S-(+)-desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
AU3839900A (en) Pharmaceutical formulation

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase